How to Lose Weight During Menopause

How to lose weight during menopause is a question many women in the UK find themselves asking, often frustrated that approaches which worked before no longer seem effective. Menopause brings a combination of hormonal shifts, metabolic changes, and disrupted sleep that can make weight management genuinely more difficult. This article explains why these changes happen, how they affect your body, and what dietary, lifestyle, and medical options are supported by current UK guidance to help you manage your weight safely and sustainably during this life stage.

Why is it so hard to lose weight during menopause?

Weight loss is harder during menopause because falling hormones, metabolic slowdown, sleep disruption, and a shift of fat towards the abdomen all occur simultaneously, compounding the natural effects of ageing.

Losing weight during menopause is harder than at other life stages because of a combination of hormonal shifts, metabolic slowdown, and changes in body composition that occur simultaneously. Menopause is defined as 12 consecutive months without a menstrual period and typically occurs between the ages of 45 and 55 in the UK, with the average age being around 51, according to the NHS menopause overview.^[1] During this transition, the body undergoes significant physiological changes that can make maintaining or reducing weight more challenging than it may have been in earlier decades, alongside the natural effects of ageing and lifestyle factors.

One of the most notable changes is a redistribution of body fat. Many women find that fat can accumulate more readily around the abdomen rather than the hips and thighs, a pattern associated with increased cardiovascular and metabolic risk. This shift can occur even when overall body weight remains stable, though individual experience varies.

Sleep disruption, which is extremely common during perimenopause and menopause due to night sweats and hormonal fluctuations, also plays a role. Poor sleep is associated with changes in appetite-regulating hormones, including ghrelin and leptin, which may make it harder to regulate appetite.^[19] Mood changes, including low mood and anxiety, can further affect eating habits and motivation to exercise. Understanding these overlapping factors is the first step towards developing a realistic and compassionate approach to weight management during this life stage.

How do hormonal changes affect your weight and metabolism?

Declining oestrogen promotes visceral fat accumulation, reduces insulin sensitivity, and compounds age-related muscle loss, all of which lower the body's resting calorie expenditure.

Declining oestrogen levels are a key hormonal factor associated with changes in body fat distribution and metabolic function during menopause, though ageing and lifestyle also contribute significantly to weight change during this period. Oestrogen plays a role in regulating body fat distribution, insulin sensitivity, and energy expenditure, and as levels fall during perimenopause and menopause, these processes may become less efficient.^[18]

As oestrogen declines, the body tends to shift fat storage from the periphery (hips, thighs, buttocks) towards visceral fat deposits around the abdomen and internal organs. Visceral fat is metabolically active and is associated with a higher risk of type 2 diabetes, cardiovascular disease, and certain cancers.^[15][16] This change can occur even in women whose total body weight remains stable.

Metabolic rate also tends to decline with age, partly due to a natural reduction in muscle mass (sarcopenia) that accelerates after the age of 40. Muscle tissue burns more calories at rest than fat tissue, so losing muscle mass reduces the number of calories the body uses each day. Hormonal changes may compound this by making it harder to build and retain muscle, even with regular exercise.

Insulin resistance, which becomes more common after menopause in some women, means the body may be less effective at using glucose for energy, increasing the likelihood that excess calories are stored as fat. Individual variability is considerable, and a GP or menopause specialist can help assess how these factors may be affecting you personally. Some research also suggests that other hormonal changes during this period may be associated with appetite and fat storage, though the evidence for specific mechanisms such as cortisol or follicle-stimulating hormone (FSH) effects is less established and should be interpreted cautiously.

What diet and lifestyle changes actually help during menopause?

A balanced diet high in protein, fibre, calcium, and vitamin D, combined with resistance training at least twice weekly and regular aerobic activity, is the most evidence-supported approach.

A combination of a balanced, nutrient-dense diet and regular physical activity remains the most evidence-supported approach to managing weight during menopause. Rather than following restrictive diets, which can worsen muscle loss and nutritional deficiencies, the focus should be on sustainable habits that support metabolic health and overall wellbeing.

Dietary principles that are particularly relevant during menopause include:

• Adequate protein intake: Protein supports muscle maintenance and promotes satiety. Sources such as lean meat, fish, eggs, legumes, and dairy are beneficial.

• Reduced ultra-processed foods: These tend to be calorie-dense and low in nutrients, and UK authoritative bodies have highlighted their association with weight gain and poorer health outcomes.

• Calcium and vitamin D: Bone density declines after menopause, so foods rich in calcium (dairy, fortified plant milks, leafy greens) and adequate vitamin D are important.

• Fibre-rich foods: Wholegrains, vegetables, fruit, and pulses support gut health, blood sugar regulation, and feelings of fullness.

Physical activity is equally important, and should include:

• Resistance or strength training: This is particularly valuable for preserving muscle mass and supporting bone density. The UK Chief Medical Officers' Physical Activity Guidelines recommend muscle-strengthening activities on at least two days per week for adults.^[5][6]

• Aerobic exercise: Brisk walking, swimming, or cycling supports cardiovascular health and calorie expenditure.

• Reducing sedentary time: The UK Chief Medical Officers also advise breaking up prolonged sitting, which has independent metabolic benefits.

Prioritising sleep hygiene and stress management, including mindfulness or relaxation techniques, can also support weight management indirectly by helping to regulate appetite and mood. Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support, and may be one option to explore alongside lifestyle changes.

Can HRT or medication help with menopause weight gain?

HRT can help redistribute visceral fat but is not a weight-loss treatment; licensed medicines such as semaglutide or tirzepatide may be considered for eligible women with a BMI of 30 kg/m² or above.

Hormone replacement therapy (HRT) does not cause weight loss directly, but it can help address some of the hormonal drivers of changes in body fat distribution during menopause, particularly the accumulation of visceral fat around the abdomen. Some evidence suggests HRT may be associated with modest improvements in visceral fat and insulin sensitivity, though findings vary and HRT is not licensed as a weight-management treatment. NICE guideline NG23 on menopause supports the use of HRT for managing menopausal symptoms, and the decision to start HRT should always involve an individualised discussion with a GP or menopause specialist, taking into account personal and family medical history, as well as any contraindications or precautions relevant to the individual.^[2][3]

HRT is available in several forms, including tablets, patches, gels, and sprays. Women who have a uterus require combined HRT (oestrogen plus progestogen) to protect the uterine lining.^[4]

For women with a body mass index (BMI) of 30 kg/m² or above who have not achieved sufficient weight loss through lifestyle changes alone, a GP may consider referral to a structured weight-management programme or, in some cases, discuss pharmacological options. Medicines licensed in the UK for chronic weight management include orlistat (available on the NHS in some circumstances), GLP-1 receptor agonists such as semaglutide injection (Wegovy) and liraglutide (Saxenda), tirzepatide (Mounjaro, which is authorised by the MHRA for both type 2 diabetes and chronic weight management), and orforglipron (Foundayo), which also holds a UK marketing authorisation for weight management.^[7][8] Oral semaglutide (Wegovy 25 mg tablets) is a further licensed option, distinct from Rybelsus, with its own dosing schedule.^[11] Eligibility criteria and commissioning arrangements differ between medicines and care settings; some but not all of these medicines have a NICE Technology Appraisal, and local Integrated Care Boards (ICBs) make commissioning decisions about NHS availability. These medicines are not suitable for everyone, and a thorough clinical assessment is required before any prescription is issued.

When should you speak to your GP about weight during menopause?

Speak to your GP if consistent lifestyle changes have not helped after several months, or if rapid weight gain, fatigue, or other symptoms suggest a condition such as hypothyroidism.

You should speak to your GP about weight during menopause if lifestyle changes have not produced results after several months of consistent effort, or if weight gain is accompanied by other symptoms that may indicate an underlying health condition. Unexplained rapid weight gain, unexplained unintentional weight loss, significant fatigue, changes in bowel habits, or new joint pain alongside weight changes are all reasons to seek a medical review rather than attributing everything to menopause alone.

Your GP can assess whether conditions such as hypothyroidism, which becomes more common in midlife and can cause weight gain and fatigue, are contributing to your symptoms.^[14] A blood test can rule out thyroid dysfunction, elevated blood glucose, or raised cholesterol, all of which are more prevalent after menopause and benefit from early identification and management.

If your BMI is above 30 kg/m², or above 27.5 kg/m² if you are of South Asian, Chinese, or Black African or Caribbean family background (lower thresholds used in some NICE guidance, including NICE PH46, to reflect differing metabolic risk), your GP can discuss referral to a structured weight-management service or consider whether pharmacological support is appropriate for you.^[12][13] They can also advise on HRT if menopausal symptoms are significantly affecting your quality of life.

Seek advice from your GP if you notice any of the following:

• Persistent weight gain despite dietary and activity changes

• Unexplained unintentional weight loss

• Symptoms that suggest a thyroid or metabolic condition

• Low mood or anxiety that is affecting your ability to manage your health

• Concerns about your cardiovascular risk or bone health

Contact NHS 111 if you need urgent advice outside of GP hours. For any life-threatening symptoms, call 999 or go to your nearest A&E department.

Scientific References

1. Menopause and perimenopause.
2. Menopause: identification and management (NG23).
3. Updated menopause guidance includes discussion aid to support clinical conversations about HRT.
4. Types of hormone replacement therapy (HRT).
5. UK Chief Medical Officers' physical activity guidelines.
6. Physical activity guidelines for adults aged 19 to 64.
7. MHRA authorises diabetes drug Mounjaro (tirzepatide) for weight management and weight loss.
8. Tirzepatide.
9. Tirzepatide: a medicine to manage type 2 diabetes and obesity.
10. UK first in Europe to authorise orforglipron for weight management and type 2 diabetes.
11. First GLP-1 tablet for weight loss approved in the UK.
12. Appendix A1: Summary of evidence from surveillance (PH46).
13. Overweight and obesity in adults.
14. Underactive thyroid (hypothyroidism).
15. Metabolic syndrome and visceral fat in women with menopause.
16. GLP-1 receptor agonists in perimenopause and early postmenopause: clinical role, cardiometabolic benefits and knowledge gaps.
17. Perimenopause and metabolic vulnerability: hormones, body composition and lifestyle changes.
18. Role of estrogen in the regulation of central and peripheral energy homeostasis: from a menopausal perspective.
19. A single night of sleep deprivation increases ghrelin levels and feelings of hunger.

Frequently Asked Questions